CRISPR J. 2020 Oct;3(5):332-349. doi: 10.1089/crispr.2020.29106.man.
In September 2020, a detailed report on was published. The report offers a translational pathway for the limited approval of germline editing under limited circumstances and assuming various criteria have been met. In this perspective, some three dozen experts from the fields of genome editing, medicine, bioethics, law, and related fields offer their candid reactions to the National Academies/Royal Society report, highlighting areas of support, omissions, disagreements, and priorities moving forward.
2020 年 9 月，发表了一份关于 的详细报告。该报告提供了一条在有限情况下对种系编辑进行有限批准的转化途径，假设已满足各种标准。从这个角度来看，来自基因组编辑、医学、生物伦理学、法律和相关领域的三十多位专家对美国国家科学院/英国皇家学会的报告提出了坦率的反应，强调了支持、遗漏、分歧和优先事项。
